DOCSLIB.ORG

In Retrospect Brandywine River Museum of Art, Chadds Ford PA, June 24 – September 17, 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
In Retrospect Brandywine River Museum of Art, Chadds Ford PA, June 24 – September 17, 2017 Selected Andrew Wyeth Exhibitions Andrew Wyeth: In Retrospect Brandywine River Museum of Art, Chadds Ford PA, June 24 – September 17, 2017. Seattle Museum of Art, Seattle WA, October 19, 2017 – January 15, 2018. Andrew Wyeth at 100 Dr. Syn, March 25, 2017 – September 10, 2017. Maine Drawings, March 18, 2017 – March 4, 2018. Maine Watercolors, April 15 – December 31, 2017. Her Room, September 15, 2017 – March 20, 2018 . Farnsworth Art Museum, Rockland ME Andrew Wyeth at 100: A Family Remembrance Fenimore Art Museum, Cooperstown NY, May 27 – September 4, 2017. Wyeth Dynasty Greenville County Museum of Art, Greenville SC, November 16, 2016 – September 10, 2017. Wyeth: Andrew and Jamie in the Studio Denver Art Museum, Denver CO, November 8, 2014 – February 7, 2016. Museo Thyssen-Bornemisza, Madrid, Spain, March 1 – June 19, 2016. Andrew Wyeth: Looking Out, Looking In National Gallery of Art, Washington DC, May 4 – November 30, 2014. Andrew Wyeth In China Yuan Space, Beijing April 14 – May 12; Hong Kong Exhibition Center, Hong Kong May 24 – 28; Christie’s, New York City September 4 – 25th, 2012. Andrew Wyeth: A Story of the Olson House Miyagi Museum of Art in Sendai, Japan May 26 – July 25, 2012. Andrew Wyeth: Looking Beyond Wadsworth Atheneum, Hartford Connecticut March 24 – July 22, 2012. The Wyeths: Three Generations of American Art Mona Bismarck Foundation, Paris November 10, 2011 – February 12, 2012. Andrew Wyeth, Christina’s World and the Olson House Farnsworth Museum of Art, Rockland Maine June 11 – October 30, 2011. Andrew Wyeth: Akvareller fran the Marunuma Art Park Collection Nordiska Akvarvellmuseet, Skarhamn Sweden May 14 – September 5, 2010. Andrew Wyeth: Emotion and Creation Bunkamura Museum of Art, Tokyo Japan November 8 – December 23, 2008; Aichi Prefectural Museum of Art, Nagoya Japan January 4 – March 8, 2009; Fukushima Prefectural Museum of Art, Fukushima Japan March 17 – May 10, 2009. Andrew Wyeth: Remembrance Seattle Art Museum, Seattle Washington June 25 – October 18, 2009. Andrew Wyeth: Master Drawings from the Artist’s Collection Brandywine River Museum, Chadds Ford Pennsylvania March 11 – July 15, 2006. Andrew Wyeth: Memory and Magic High Museum of American Art, Atlanta November 12 – February 26, 2006; Philadelphia Museum of Art, Philadelphia, Pennsylvania March 29 – July 16, 2006. Andrew Wyeth: Early Watercolors Currier Museum of Art, Manchester New Hampshire October 8, 2004 – January 10, 2005; Farnsworth Art Museum, Rockland, Maine April 6 – September 18, 2005; Brandywine River Museum, Chadds Ford, Pennsylvania October 1 – November 20, 2005. Andrew Wyeth: Close Friends Mississippi Museum of Art, Jackson Mississippi February 3 – May 13, 2001; Greenville County Museum of Art, Greenville South Carolina June 6 – August 26, 2001; Telfair Academy of Arts and Sciences, Savannah Georgia September 13 – December 31, 2001. Andrew Wyeth: Watercolors and Drawings Fukushima Prefectural Museum of Art, Fukushima-City, Japan February 23 – April 8, 2000; Hiratsuka Museum of Art, Hiratsuka-City, Japan October 14 – November 26, 2000; Museum of Fine Art, Gifu-City, Japan December 15, 2000 – February 12, 2001. Andrew Wyeth: Her Room Bates College Museum of Art, Lewiston Maine November 3, 2000 – March 30, 2001. Wondrous Strange – The Wyeth Tradition – Howard Pyle, N. C. Wyeth, Andrew Wyeth, James Wyeth Farnsworth Art Museum, Rockland Maine June 21 – November 8, 1998; Delaware Art Museum, Wilmington Delaware December 10, 1998 – February 21, 1999. Unknown Terrain: Landscapes of Andrew Wyeth Whitney Museum of American Art, New York May 28 – August 30, 1998; Hermitage Museum, St. Petersburg Russia October 18, 1998 – January 10, 1999. Andrew Wyeth – America’s Painter Greenville County Museum of Art, Greenville South Carolina June 18 – September 15; Baltimore Museum of Art, Baltimore Maryland September 25, 1996 – February 16, 1997. Andrew Wyeth – Autobiography Aichi Prefectural Museum, Nagoya, Japan February 3 – April 2, 1995; Bunkamura Museum of Art, Tokyo, Japan April 15 – June 4, 1995; Fukushima Prefectural Museum of Art, Fukushima-City, Japan June 6 – July 16, 1995; Nelson-Atkins Museum, Kansas City, Missouri September 24 – November 26, 1995. Andrew Wyeth Gallerie Forni, Bologna, Italy March 28 – April 28, 1992. Andrew Wyeth: The Helga Pictures National Gallery of Art, Washington DC May 24 – September 27; Museum of Fine Arts, Boston October 28, 1987 – January 3, 1988; The Museum of Fine Arts Houston January 31 – April 4, 1988; Fine Arts Museum of San Francisco August 13 – October 16, 1988; Detroit Institute of Arts November 13, 1988 – January 22, 1989; Brooklyn Museum of Art, New York June 19 – September 18, 1989. An American Vision: Three Generations of Wyeth Art Academy of the Arts of the U.S.S.R., Leningrad March 11 – April 12, 1987; Academy of the Arts of the U.S.S.R., Moscow April 24 – May 31, 1987; Corcoran Gallery of Art Washington DC July 4 – August 3, 1987; Dallas Museum of Art, Dallas Texas September 29 – November 29, 1987; Terra Museum of American Art, Chicago Illinois December 13, 1987 – February 14, 1988; Setagaya, Tokyo March 10 – April 21, 1988; Palazzo Reale, Milan Italy May 17 – June 20, 1988; Fitzwilliam Museum, Cambridge England July 12 – August 29, 1988; Brandywine River Museum, Chadds Ford Pennsylvania September 17 – November 22, 1988. Andrew Wyeth – A Trojan Horse Modernist Greenville County Museum of Art, Greenville South Carolina March 9 – April 15, 1984. Andrew Wyeth Royal Academy of the Arts, London June 6 – August 31, 1980. Andrew Wyeth – Temperas, Aquarelles, Drybrush, Dessins Galerie Claude Bernard, Paris December 2, 1980 – January 31, 1981. Works by Andrew Wyeth from the Holly and Arthur Magill Collection Greenville County Museum of Art, Greenville South Carolina opening September 11, 1979. Two Worlds of Andrew Wyeth: Kuerners and Olsons Metropolitan Museum of Art, New York October 16, 1976 – February 6, 1977. Brandywine Heritage ’74 – Pyle, Wyeth, Wyeth, Wyeth Museum of Art, Science & Industry, Bridgeport Connecticut April 20 – May 23, 1974. Andrew Wyeth The Lefevre Gallery, London May 23 – June 22, 1974. Andrew Wyeth National Museum of Modern Art, Tokyo April 6 – May 19; The Nihon Keizai Shimbun, Kyoto, Japan May 25 – June 30, 1974. The Art of Andrew Wyeth The Fine Arts Museums of San Francisco, San Francisco California June 16 – September 3, 1973. Andrew Wyeth The White House, Washington DC February 19 – March 28, 1970. Andrew Wyeth Museum of Fine Arts, Boston July 17 – September 6, 1970. Andrew Wyeth – Temperas, Watercolors, Dry Brush, Drawings, 1938 – 1966 Pennsylvania Academy of the Fine Arts, Philadelphia October 5 – November 27, 1966; Baltimore Museum of Art, Baltimore Maryland December 11, 1966 – January 22, 1967; Whitney Museum of American Art, New York City February 6 – April 12 1967; Art Institute of Chicago, Chicago Illinois April 21 – June 4, 1967. Andrew Wyeth – Dry Brush and Pencil Drawings Fogg Art Museum, Cambridge Massachusetts January 15 – February 28, 1963; Pierpont Morgan Library, New York March 14 – April 27, 1963; Corcoran Gallery of Art, Washington DC May 19 – June 16, 1963. Andrew Wyeth, Temperas, Water Colors and Drawings Buffalo Fine Arts Academy, Albright-Knox Art Gallery, Buffalo New York November 2 – December 9, 1962. American Watercolor Exhibition National Museum of Modern Art, Tokyo August – September, 1956. Andrew Wyeth M. H. de Young Memorial Museum, San Francisco California July 12 – August 12, 1956; Santa Barbara Museum of Art, Santa Barbara California August 28 – September 23, 1956. Andrew Wyeth M. Knoedler & Company, Inc., New York October 26 – November 14, 1953. Paintings and Drawings by Andrew Wyeth Currier Gallery of Art, Manchester, NH July 7 – August 4, 1951; William A. Farnsworth Library and Art Museum Rockland, ME August 10 – September 8, 1951. Symbolic Realism in American Painting: 1940 – 1950 Institute of Contemporary Arts, London July 18 – August 18, 1950. Paintings by Maine Artists William A. Farnsworth Library and Art Museum, Rockland Maine October 12 – 30, 1950. Andrew Wyeth Pennsylvania Academy of Art, Philadelphia April 8 – 20, 1947. Americans 1943: American Realists and Magic Realists Museum of Modern Art, New York February 10 – March 21, 1943; Albright-Knox Gallery, Buffalo New York April 4 – May 5, 1943; Minneapolis Museum of Art, Minneapolis Minnesota June 1 – 30, 1943; San Francisco Museum of Art, California August 23 – September 19, 1943; Toronto Art Gallery, Canada November 12 – December 19, 1943; Cleveland Museum of Art, Ohio January 6 – February 6, 1944. Watercolors by Andrew Wyeth Currier Museum of American Art, Manchester New Hampshire April 1939 (specific dates unknown). Drawings and Lithographs of Peter Hurd and Watercolors and Drawings by Andrew Wyeth Corcoran Gallery of Art, Washington DC December 2 – 22, 1939. Water Colors by Andrew Wyeth Macbeth Gallery, New York October 19 – November 1, 1937. Work by the Wyeth Family Philadelphia Art Alliance, Pennsylvania March 25 – April 19, 1935. Nineteenth Annual Exhibition – Delaware Artists, Pupils of Howard Pyle, Members of the Society The Wilmington Society of the Fine Arts, Wilmington DE November 7 – 27, 1932.
Load more

Recommended publications
  • Print Layout 1
    TECHNICAL PROGRAM Monday, March 19 5:00 – 8:00 pm Welcome Reception Tuesday, March 20 8:00 – 10:00 Session 1: Setting the Conference Context and Drivers Chair: Geoff Slaff (Amgen) Roger Perlmutter (Amgen) Conquering the Innovation Deficit in Drug Discovery Helen Winkle (CDER, FDA) Regulatory Modernization 10:00 – 10:30 Break Vendor and poster review 10:30 – 12:30 Session 2: Rapid Cell Line Development and Improved Expression System Development Chairs: Timothy Charlebois (Wyeth) and John Joly (Genentech) Amy Shen (Genentech) Stable Antibody Production Cell-Line Development with an Improved Selection Process and Accelerated Timeline Mark Leonard (Wyeth) High-Performing Cell-Line Development within a Rapid and Integrated Platform Process Control Pranhitha Reddy (Amgen) Applying Quality-by-Design to Cell Line Development Lin Zhang (Pfizer) Development of a Fully-Integrated Automated System for High-Throughput Screening and Selection of Single Cells Expressing Monoclonal Antibodies 12:30 – 2:00 Lunch Vendor and poster review 2:00 – 4:30 Session 3: High-Throughput Bulk Process Development Chairs: Brian Kelley (Wyeth) and Jorg Thommes (Biogen Idec) Colette Ranucci (Merck) Development of a Multi-Well Plate System for High-Throughput Process Development Min Zhang (SAFC Biosciences) CHO Media Library – an Efficient Platform for Rapid Development and Optimization of Cell Culture Media Supporting High Production of Pharmaceutical Proteins in Chinese Hamster Ovary Cells Nigel Titchener-Hooker The Use of Ultra-Scale-Down Approaches to Enable Rapid Investigation
    [Show full text]
  • THE CLEVELAN ORCHESTRA California Masterwor S
    ����������������������� �������������� ��������������������������������������������� ������������������������ �������������������������������������� �������� ������������������������������� ��������������������������� ��������������������������������������������������� �������������������� ������������������������������������������������������� �������������������������� ��������������������������������������������� ������������������������ ������������������������������������������������� ���������������������������� ����������������������������� ����� ������������������������������������������������ ���������������� ���������������������������������������� ��������������������������� ���������������������������������������� ��������� ������������������������������������� ���������� ��������������� ������������� ������ ������������� ��������� ������������� ������������������ ��������������� ����������� �������������������������������� ����������������� ����� �������� �������������� ��������� ���������������������� Welcome to the Cleveland Museum of Art The Cleveland Orchestra’s performances in the museum California Masterworks – Program 1 in May 2011 were a milestone event and, according to the Gartner Auditorium, The Cleveland Museum of Art Plain Dealer, among the year’s “high notes” in classical Wednesday evening, May 1, 2013, at 7:30 p.m. music. We are delighted to once again welcome The James Feddeck, conductor Cleveland Orchestra to the Cleveland Museum of Art as this groundbreaking collaboration between two of HENRY COWELL Sinfonietta
    [Show full text]
  • To See Anew: Experiencing American Art in the 21St Century
    Initiatives in Art and Culture To See Anew: Experiencing American Art in the 21st Century 21ST ANNUAL AMERICAN ART CONFERENCE FRIDAY – SATURDAY, MAY 20 – 21, 2016 1851, after an original of 1851, The Greek Slave, The Greek Stuart Davis, Swing Landscape, 1938, oil on canvas, 86¾ x 172⅞ in. Indiana University Art Museum, Bloomington, Indiana. © Estate of Stuart Davis/Licensed Hiram Powers, Powers, Hiram Art University x 18¼ in. Yale 1844, marble, 65¼ x 21 Dann Fund. 1962.43, Olive Louise Gallery, by VAGA, New York, NY. Jonathan Boos. Jonathan Boos. 36 x 29 in. Private collection; photo: courtesy, canvas, Guy Pène du Bois, Country Wedding, Henry Peters Gray, The Wages of War, 1848, oil on 1929, oil on canvas, 48¼ x 76¼ in. The Metropolitan Museum of Art, gift of Several Ladies and Gentlemen, 1873. 73.5. THE GRADUATE CENTER, THE CITY UNIVERSITY OF NEW YORK To See Anew: Experiencing American Art in the 21st Century 21ST ANNUAL AMERICAN ART CONFERENCE Heilbrun, 1922). Chanler. Robert Winthrop Ivan Narodny, (from: 1921 Chanler, Robert Winthrop New York: William New York: Avian Arabesque, Avian Arabesque, The Art of In this conference, Initiatives in Art and Culture considers iconic works by recognized masters, seeking to understand both why they were celebrated in their own time and why they retain their power today. At the same time, we explore the works of artists who did not retain the renown they enjoyed during their lifetimes and who fell into obscurity. But obscurity is not necessarily forever, and as cycles of taste have changed, these once-forgotten artists and their largely unknown works have re-surfaced to startle us today.
    [Show full text]
  • Moderna Vaccine Day Presentation
    Zika Encoded VLP mRNA(s) RSV CMV + EBV SARS-CoV- RSV-ped 2 Flu hMPV/PIV3 H7N9 Encoded mRNA(s) Ribosome Protein chain(s) First Vaccines Day April 14, 2020 © 2020 M oderna Therapeutics Forward-looking statements and disclaimers This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended including, but not limited to, statements concerning; the impact of the SARS-CoV-2 pandemic on the Company’s clinical trials and operations; the timing and finalization of a dose-confirmation Phase 2 study and planning for a pivotal Phase 3 study for mRNA-1647; the status and outcome of the Phase 1 clinical trial for mRNA-1273 being conducted by NIH; the next steps and ultimate commercial plan for mRNA-1273; the size of the potential market opportunity for mRNA-1273; the size of the potential commercial market for novel vaccines produced by Moderna or others; the potential peak sales for the Company’s wholly-owned vaccines; the probability of success of the Company’s vaccines individually and as a portfolio; and the ability of the Company to accelerate the research and development timeline for any individual product or the platform as a whole. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements.
    [Show full text]
  • Celebrating Andrew Wyeth the American Artist’S Centennial Is Being Honored with Two Major Retrospectives of His Work
    along the way Celebrating Andrew Wyeth The American artist’s centennial is being honored with two major retrospectives of his work. Andrew Wyeth may have been a favorite of U.S. presidents. In 1963, he became the first painter to receive the Presidential Medal of Freedom when John F. Kennedy bestowed the honor. Richard Nixon once sponsored a White House exhibition of works by the Pennsylvania- and Maine- based artist, and both Bushes honored Wyeth, with the Congressional Gold Medal in 1990 and the National Medal of the Arts in 2007. At the other end of the spectrum, comic- strip character Snoopy owned a Wyeth that he displayed prominently in his doghouse. In between, the artist was alternately lauded and dismissed by critics but remained a perennial commercial favorite. This year marks the centennial of Wyeth’s birth, and two major museum retrospectives have been assembled NORTH CAROLINA MUSEUM OF ART, RALEIGH ART, OF MUSEUM CAROLINA NORTH ©ANDREW WYETH/ARTISTS RIGHTS SOCIETY (ARS), RIGHTS WYETH/ARTISTS ©ANDREW for the occasion. Andrew Wyeth at 100 can be seen at Winter 1946, tempera, Andrew Wyeth (1917-2009) the Farnsworth Art Museum in Rockland, Maine, through December 31 (farnsworthmuseum.org), and Andrew in Andrew Wyeth: Maine Watercolors, 1938–2008, the focal Wyeth: In Retrospect is on display through September exhibition in a series of five exhibitions that make upAndrew 17 at the Brandywine River Museum in Chadds Ford, Wyeth at 100, on display at the museum’s Wyeth Center and in Pennsylvania (brandywinemuseum.org), and from October its Hadlock and Wyeth Study Center galleries.
    [Show full text]
  • SR Books March 2018.Pdf
    Sunriver Books & Music March 2018 Newsletter Sunriverbooks.com 541-593-2525 Saturday March 31st at 5:00 PM Jennifer Haupt will give a slide show presentation on her moving novel, In The Shadow of 10,000 Hills. Jennifer Haupt spent 25 years as a journalist writing for such pres- tigious publications as O’ Oprah’s magazine, The Seattle Times and Psychology Today. In 2006 she traveled to Rwanda to interview survivors of the genocide. From her experiences she was inspired to write this uplifting novel that intersects the story of a young American woman, Rachel, and the people she meets in Rwanda who will ultimately show her the meaning of grace and home. Lillian Carlson met Henry Shepard at a speech by Martin Luther King Jr., the attraction was instant. Henry was at the event as a newspaper photographer, trying to get his career going, passionate about photog- raphy. Later, the shot he took of Lillian would grace the cover of Life magazine. But in the 1960’s the world was not ready to embrace a rela- tionship between a white man and a black woman. They moved on, Henry married his high school sweetheart, Merilee, and had a daughter, Rachel. The marriage was not happy, Merilee did not understand Henry’s artistic passions, she wanted stability. When Rachel was 8 Henry learned that Lillian had moved to Africa, opening a small orphanage in Rwanda. He had a few dollars set aside and decid- ed he must take this chance, go to Africa and try to prove he could make it as a serious photographer.
    [Show full text]
  • Wyeth Pharmaceuticals Inc., a Subsidiary of Pfizer Inc Mylotarg
    Mylotarg FDA ODAC Briefing Document 11 July 2017 WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC MYLOTARG (gemtuzumab ozogamicin; PF-05208747) In combination with chemotherapy for the treatment of previously untreated de novo CD33-positive acute myeloid leukemia and as monotherapy for the treatment of CD33-positive acute myeloid leukemia in first relapse FDA ONCOLOGIC DRUGS ADVISORY COMMITTEE BRIEFING DOCUMENT (BLA 761060) Meeting Date: 11 July 2017 ADVISORY COMMITTEE BRIEFING MATERIALS: AVAILABLE FOR PUBLIC RELEASE 090177e18c1aa788\Approved\Approved On: 12-Jun-2017 13:05 (GMT) Page 1 Mylotarg FDA ODAC Briefing Document 11 July 2017 TABLE OF CONTENTS TABLE OF CONTENTS...........................................................................................................2 LIST OF TABLES.....................................................................................................................5 LIST OF FIGURES ...................................................................................................................6 1. EXECUTIVE SUMMARY .................................................................................................7 1.1. Introduction..............................................................................................................7 1.2. Rationale for Mylotarg Dosing Regimens ...............................................................8 1.3. Mylotarg in Patients With Previously Untreated De Novo AML............................9 1.4. Mylotarg in Patients With AML in First Relapse..................................................11
    [Show full text]
  • New Mexico and the Arts of Enchantment
    April, May, June 2014 New Mexico and the Arts of Enchantment featuring The Raymond James Financial Collection 1 MFA’s Andrew Wyeth Watercolor Director’s Welcome Travels to National Gallery of Art Dear Friends, Wisteria (1981), the MFA’s prized watercolor by Andrew Wyeth, has The Museum doesn’t take been selected for the exhibition, Andrew Wyeth: Looking Out, Looking In, a spring break or summer which will be on view at the National Gallery of Art in Washington, vacation, so I hope you will D.C., from May 4-November 30, 2014. Comprised of approximately 45 spend your free time with us. choice works, this is the first exhibition to explore Wyeth’s use of the You can travel to New Mexico, window in his art and honors the recent gift of his painting Wind from China, and around the world the Sea to the National Gallery. by simply walking through our doors and enjoying our special exhibitions and collection. New Mexico and the Arts of Enchantment featuring The Raymond James Financial Collection is magical. With more than 100 works, it is one of the most diverse exhibitions we have ever presented – from pre-Hispanic pottery to twenty-first century paintings and sculpture. You will not want to miss the contemporary jewelry Mary James has graciously lent to the exhibition. We are profoundly grateful to Mary and Tom James, Raymond James Financial, and the other generous collectors for sharing some of their favorite works with the community. I also want to thank Hazel and William Hough Chief Curator Jennifer Hardin and the entire curatorial staff for their dedication and creativity.
    [Show full text]
  • Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
    Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers August 4, 2009 THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Aug. 4 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) announcement regarding the results of a safety review of Tumor Necrosis Factor (TNF) blockers [marketed as Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol) and Simponi (golimumab)]. This safety review was the subject of an FDA Early Communication in June 2008 pertaining to cases of malignancy in pediatric patients exposed to a TNF blocker. As a result of this review, the FDA has required strengthened warnings about the occurrence of lymphoma and other cancers in children and young adults using these medicines. AMGEN AND WYETH STATEMENT: Amgen and Wyeth believe that ENBREL continues to offer a favorable benefit-risk relationship for patients with the diseases for which it is indicated to treat, including moderate to severe Juvenile Idiopathic Arthritis (JIA). JIA can be a serious and potentially debilitating condition. Amgen will work with the FDA to update the U.S. Prescribing Information, and Medication Guide for ENBREL as described in the FDA communication which can be read at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm175803.htm. In addition, Amgen and Wyeth will communicate the revised product labeling to both physicians and patients. ENBREL was first approved for JIA in the U.S. in 1999. It is estimated through postmarketing data that approximately 13,847 pediatric patients have been treated with ENBREL globally through February 2009, accounting for approximately 44,600 patient-years of exposure.
    [Show full text]
  • READ ME FIRST Here Are Some Tips on How to Best Navigate, find and Read the Articles You Want in This Issue
    READ ME FIRST Here are some tips on how to best navigate, find and read the articles you want in this issue. Down the side of your screen you will see thumbnails of all the pages in this issue. Click on any of the pages and you’ll see a full-size enlargement of the double page spread. Contents Page The Table of Contents has the links to the opening pages of all the articles in this issue. Click on any of the articles listed on the Contents Page and it will take you directly to the opening spread of that article. Click on the ‘down’ arrow on the bottom right of your screen to see all the following spreads. You can return to the Contents Page by clicking on the link at the bottom of the left hand page of each spread. Direct links to the websites you want All the websites mentioned in the magazine are linked. Roll over and click any website address and it will take you directly to the gallery’s website. Keep and fi le the issues on your desktop All the issue downloads are labeled with the issue number and current date. Once you have downloaded the issue you’ll be able to keep it and refer back to all the articles. Print out any article or Advertisement Print out any part of the magazine but only in low resolution. Subscriber Security We value your business and understand you have paid money to receive the virtual magazine as part of your subscription. Consequently only you can access the content of any issue.
    [Show full text]
  • Mvx List.Pdf
    MVX_CODE manufacturer_name Notes status last updated date manufacturer_id AB Abbott Laboratories includes Ross Products Division, Solvay Inactive 16-Nov-17 1 ACA Acambis, Inc acquired by sanofi in sept 2008 Inactive 28-May-10 2 AD Adams Laboratories, Inc. Inactive 16-Nov-17 3 ALP Alpha Therapeutic Corporation Inactive 16-Nov-17 4 AR Armour part of CSL Inactive 28-May-10 5 AVB Aventis Behring L.L.C. part of CSL Inactive 28-May-10 6 AVI Aviron acquired by Medimmune Inactive 28-May-10 7 BA Baxter Healthcare Corporation-inactive Inactive 28-May-10 8 BAH Baxter Healthcare Corporation includes Hyland Immuno, Immuno International AG,and North American Vaccine, Inc./acquired somInactive 16-Nov-17 9 BAY Bayer Corporation Bayer Biologicals now owned by Talecris Inactive 28-May-10 10 BP Berna Products Inactive 28-May-10 11 BPC Berna Products Corporation includes Swiss Serum and Vaccine Institute Berne Inactive 16-Nov-17 12 BTP Biotest Pharmaceuticals Corporation New owner of NABI HB as of December 2007, Does NOT replace NABI Biopharmaceuticals in this codActive 28-May-10 13 MIP Emergent BioSolutions Formerly Emergent BioDefense Operations Lansing and Michigan Biologic Products Institute Active 16-Nov-17 14 CSL bioCSL bioCSL a part of Seqirus Inactive 26-Sep-16 15 CNJ Cangene Corporation Purchased by Emergent Biosolutions Inactive 29-Apr-14 16 CMP Celltech Medeva Pharmaceuticals Part of Novartis Inactive 28-May-10 17 CEN Centeon L.L.C. Inactive 28-May-10 18 CHI Chiron Corporation Part of Novartis Inactive 28-May-10 19 CON Connaught acquired by Merieux Inactive 28-May-10 21 DVC DynPort Vaccine Company, LLC Active 28-May-10 22 EVN Evans Medical Limited Part of Novartis Inactive 28-May-10 23 GEO GeoVax Labs, Inc.
    [Show full text]
  • FDA Listing of Authorized Generics As of July 1, 2021
    FDA Listing of Authorized Generics as of July 1, 2021 Note: This list of authorized generic drugs (AGs) was created from a manual review of FDA’s database of annual reports submitted to the FDA since January 1, 1999 by sponsors of new drug applications (NDAs). Because the annual reports seldom indicate the date an AG initially entered the market, the column headed “Date Authorized Generic Entered Market” reflects the period covered by the annual report in which the AG was first reported. Subsequent marketing dates by the same firm or other firms are not included in this listing. As noted, in many cases FDA does not have information on whether the AG is still marketed and, if not still marketed, the date marketing ceased. Although attempts have been made to ensure that this list is as accurate as possible, given the volume of d ata reviewed and the possibility of database limitations or errors, users of this list are cautioned to independently verify the information on the list. We welcome comments on and suggested changes (e.g., additions and deletions) to the list, but the list may include only information that is included in an annual report. Please send suggested changes to the list, along with any supporting documentation to: [email protected] A B C D E F G H I J K L M N O P Q R S T U V X Y Z NDA Applicant Date Authorized Generic Proprietary Name Dosage Form Strength Name Entered the Market 1 ACANYA Gel 1.2% / 2.5% Bausch Health 07/2018 Americas, Inc.
    [Show full text]